Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

FGFRL1 affects chemoresistance of small‐cell lung cancer by modulating the PI3K/Akt pathway via ENO1

19 Jan 2020

Abstract excerpt

Fibroblast growth factor receptor-like 1 (FGFRL1), a member of the FGFR family, has been demonstrated to play important roles in various cancers. However, the role of FGFRL1 in small-cell lung cancer (SCLC) remains unclear. Our study aimed to investigate the role of FGFRL1 in chemoresistance of SCLC and elucidate the possible molecular mechanism. We found that FGFRL1 levels are significantly up-regulated in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Fibroblast Growth Factor Research
Share to Lung Cancer Research Studies
Share to Neuroendocrine Tumor Research Advances

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 31957179
DOI: 10.1111/jcmm.14763

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

FGFRL1 affects chemoresistance of small‐cell lung cancer by modulating the PI3K/Akt pathway via ENO1PMID 31957179Read ↗

ERO1L promotes NSCLC development by modulating cell cycle‐related moleculesSemantic proximity Read ↗

NRBF2 regulates the chemoresistance of small cell lung cancer by interacting with the P62 protein in the autophagy processSemantic proximity Read ↗

FOXO1, a tiny protein with intricate interactions: Promising therapeutic candidate in lung cancerSemantic proximity Read ↗

[Progress on the Study of Targeting FGFR in Squamous Non-small Cell Lung Cancer].Semantic proximity Read ↗

FOXM1 is required for small cell lung cancer tumorigenesis and associated with poor clinical prognosisSemantic proximity Read ↗

Reciprocal expression of INSM1 and YAP1 defines subgroups in small cell lung cancerSemantic proximity Read ↗

PI3K/Akt/mTOR signaling orchestrates the phenotypic transition and chemo-resistance of small cell lung cancer.Semantic proximity Read ↗

Fibroblast growth factor receptor-mediated signals contribute to the malignant phenotype of non-small cell lung cancer cells: therapeutic implications and synergism with epidermal growth factor receptor inhibition.Semantic proximity Read ↗

FGFR1 signaling potentiates tumor growth and predicts poor prognosis in esophageal squamous cell carcinoma patientsSemantic proximity Read ↗

FGFR1 Is Critical for RBL2 Loss–Driven Tumor Development and Requires PLCG1 Activation for Continued Growth of Small Cell Lung CancerSemantic proximity Read ↗

Role of Notch1 Signaling Pathway in Small Cell Lung CarcinomaSemantic proximity Read ↗

PYCR1 knockdown inhibits the proliferation, migration, and invasion by affecting JAK/STAT signaling pathway in lung adenocarcinomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.